Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
公司代碼BDX
公司名稱Becton Dickinson and Co
上市日期Oct 31, 2099
CEOPolen (Thomas E)
員工數量72000
證券類型Ordinary Share
年結日Oct 31
公司地址One Becton Drive
城市FRANKLIN LAKES
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編07417-1880
電話12018476800
網址https://www.bd.com/
公司代碼BDX
上市日期Oct 31, 2099
CEOPolen (Thomas E)